Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2022/10/20/2538895/0/en/Summit-Therapeutics-Presents-Ri-CoDIFy-Trial-Results-for-Microbiome-Sparing-Ridinilazole-at-IDWeek-2022.html

GLOBENEWSWIRE
20 Oct 2022

https://www.globenewswire.com/news-release/2022/10/13/2533796/0/en/Summit-Therapeutics-to-Present-Ri-CoDIFy-Trial-Results-for-Microbiome-Sparing-Ridinilazole-at-IDWeek-2022.html

GLOBENEWSWIRE
13 Oct 2022

https://www.globenewswire.com/news-release/2022/07/14/2479712/0/en/Summit-Therapeutics-Provides-Update-on-Ridinilazole.html

GLOBENEWSWIRE
14 Jul 2022
Summit will take scenic route up FDA mountain
Summit will take scenic route up FDA mountain

14 Jul 2022

// Annalee Armstrong FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/summit-will-take-scenic-route-fda-mountain-after-c-diff-convo-regulator

Annalee Armstrong FIERCEBIOTECH
14 Jul 2022
Summit turns to partnerships for failed C. difficile med
Summit turns to partnerships for failed C. difficile med

19 Mar 2022

// Max Bayerf FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/summit-carves-out-path-forward-after-c-diff-failure-remains-committed-lead-asset

Max Bayerf FIERCEBIOTECH
19 Mar 2022

https://endpts.com/billionaire-bob-duggans-new-antibiotic-play-fails-a-phase-iii-trial-and-investors-arent-happy/

N. DeFeudis ENDPTS
22 Dec 2021